Lixte Biotechnology Holdings Inc (LIXT)
2.460
+0.08
(+3.38%)
USD |
NASDAQ |
May 17, 16:00
2.29
-0.17
(-6.93%)
After-Hours: 20:00
Lixte Biotechnology Holdings Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 28, 2024 | 15.37 |
March 27, 2024 | 16.00 |
March 26, 2024 | 10.25 |
March 25, 2024 | 10.25 |
March 22, 2024 | 10.00 |
March 21, 2024 | 10.50 |
March 20, 2024 | 10.50 |
March 19, 2024 | 10.46 |
March 18, 2024 | 11.14 |
March 15, 2024 | 10.50 |
March 14, 2024 | 10.32 |
March 13, 2024 | 10.82 |
March 12, 2024 | 10.73 |
March 11, 2024 | 11.40 |
March 08, 2024 | 11.05 |
March 07, 2024 | 11.55 |
March 06, 2024 | 11.00 |
March 05, 2024 | 11.16 |
March 04, 2024 | 11.23 |
March 01, 2024 | 11.01 |
February 29, 2024 | 11.82 |
February 28, 2024 | 12.25 |
February 27, 2024 | 12.14 |
February 26, 2024 | 10.05 |
February 23, 2024 | 10.09 |
Date | Value |
---|---|
February 22, 2024 | 10.76 |
February 21, 2024 | 10.55 |
February 20, 2024 | 12.18 |
February 16, 2024 | 12.68 |
February 15, 2024 | 12.37 |
February 14, 2024 | 12.14 |
February 13, 2024 | 12.41 |
February 12, 2024 | 11.82 |
February 09, 2024 | 10.50 |
February 08, 2024 | 9.365 |
February 07, 2024 | 9.592 |
February 06, 2024 | 9.502 |
February 05, 2024 | 9.183 |
February 02, 2024 | 9.320 |
February 01, 2024 | 9.638 |
January 31, 2024 | 9.547 |
January 30, 2024 | 9.638 |
January 29, 2024 | 9.774 |
January 26, 2024 | 9.047 |
January 25, 2024 | 9.411 |
January 24, 2024 | 8.456 |
January 23, 2024 | 9.774 |
January 22, 2024 | 9.729 |
January 19, 2024 | 9.774 |
January 18, 2024 | 7.865 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.085
Minimum
Sep 23 2022
373.49
Maximum
May 24 2019
23.58
Average
9.651
Median
Price to Book Value Benchmarks
iBio Inc | 0.7501 |
PAVmed Inc | -- |
Moleculin Biotech Inc | 0.544 |
Syros Pharmaceuticals Inc | 9.674 |
Nutriband Inc | 7.616 |
Price to Book Value Related Metrics
Price | 2.460 |
Earnings Yield | -94.70% |
Market Cap | 5.534M |